Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings
August 14, 2026
Cannabics Pharmaceuticals Appoints a Second Independent Board Member
July 20, 2021
Related Post
-
-
Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement
August 13, 2026
-
Curis, Inc. Announces Pricing of $5.6 Million Public Offering
August 13, 2026
-
Cure Sanfilippo Foundation and National MPS Society Make $5.5 Million Strategic Investment in Spruce Biosciences
August 12, 2026